Related Experiment Video
Updated: Jul 9, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes
Timothy Cardozo1, Michele Pagano
1Department of Pharmacology NYU Cancer Institute, New York University School of Medicine, 550 First Avenue MSB 599, New York, NY 10016, USA. timc@saturn.med.nyu.edu
Abstract:
Recently, the ubiquitin proteasome system (UPS) has matured as a drug discovery arena, largely on the strength of the proven clinical activity of the proteasome inhibitor Velcade in multiple myeloma. Ubiquitin ligases tag cellular proteins, such as oncogenes and tumor suppressors, with ubiquitin. Once tagged, these proteins are degraded by the proteasome. The specificity of this degradation system for particular substrates lies with the E3 component of the ubiquitin ligase system (ubiquitin is transferred from an E1 enzyme to an E2 enzyme and finally, thanks to an E3 enzyme, directly to a specific substrate). The clinical effectiveness of Velcade (as it theoretically should inhibit the output of all ubiquitin ligases active in the cell simultaneously) suggests that modulating specific ubiquitin ligases could result in an even better therapeutic ratio. At present, the only ubiquitin ligase leads that have been reported inhibit the degradation of p53 by Mdm2, but these have not yet been developed into clinical therapeutics. In this review, we discuss the biological rationale, assays, genomics, proteomics and three-dimensional structures pertaining to key targets within the UPS (SCFSkp2 and APC/C) in order to assess their drug development potential. Publication history: Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).
Insights
The ubiquitin proteasome system (UPS) is a key drug target. Modulating specific E3 ubiquitin ligases, like SCFSkp2 and APC/C, offers potential for improved cancer therapeutics beyond current proteasome inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- The ubiquitin proteasome system (UPS) is crucial for cellular protein degradation.
- Proteasome inhibitors like Velcade show clinical efficacy in multiple myeloma.
- Specificity in UPS-mediated degradation is determined by E3 ubiquitin ligases.
Purpose of the Study:
- To review the drug development potential of key UPS targets.
- To assess SCFSkp2 and APC/C as therapeutic targets.
- To explore the biological rationale, assays, and structural data for UPS targets.
Main Methods:
- Literature review of biological rationale, genomics, proteomics, and 3D structures.
- Analysis of E3 ubiquitin ligase function and substrate specificity.
- Evaluation of drug development potential for UPS targets.
Main Results:
- The UPS is a validated drug discovery arena.
- Modulating specific E3 ligases may offer better therapeutic ratios than broad proteasome inhibition.
- SCFSkp2 and APC/C are identified as key targets for UPS-based drug development.
Conclusions:
- Targeting specific E3 ubiquitin ligases within the UPS presents a promising strategy for novel therapeutics.
- Further research into SCFSkp2 and APC/C could lead to new cancer treatments.
- The UPS continues to be a fertile ground for developing targeted protein degradation therapies.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
10:50Using In Vitro Fluorescence Resonance Energy Transfer to Study the Dynamics Of Protein Complexes at a Millisecond Time Scale
Published on: March 14, 2019
Related Concept Videos
Anaphase Promoting Complex
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Drug Discovery: Overview